钌配合物稳定端粒DNA的作用及其诱导细胞凋亡分子机制的研究

doi:10.6023/A13101092

化学学报 ›› 2014, Vol. 72 ›› Issue (4): 473-480.DOI: 10.6023/A13101092 上一篇下一篇

研究论文

钌配合物稳定端粒DNA的作用及其诱导细胞凋亡分子机制的研究

刘莹^a, 陈小曼^a, 张朗棋^a, 孙冬冬^a, 周艳晖^a, 陈兰美^a,b, 刘杰^a

a 暨南大学化学系广州 510632;
b 广东医学院药学院湛江 524023

投稿日期:2013-10-25 发布日期:2014-01-14
通讯作者: 刘杰 E-mail：tliuliu@jnu.edu.cn （Jie Liu）; Tel./Fax ：+86-20-8522-0223 E-mail:tliuliu@jnu.edu.cn
基金资助:
项目受国家自然科学基金（Nos.21171070，21371075）、广东省科技计划项目（No.c1211220800571）及广东省自然科学基金和中央高校基本科研业务费专项资金资助.

Stabilization of Telomere DNA, and Mechanism of Apoptosis of Tumor Cells Induced by Ruthenium Complexes

Liu Ying^a, Chen Xiaoman^a, Zhang Langqi^a, Sun Dongdong^a, Zhou Yanhui^a, Chen Lanmei^a,b, Liu Jie^a

a Department of Chemistry, Jinan University, Guangzhou 510632;
b School of Pharmacy, Guangdong Medical College, Zhanjiang 524023

Received:2013-10-25 Published:2014-01-14
Supported by:
Project supported by the National Natural Science Foundation of China (Nos. 21171070, 21371075), the Planned Item of Science and Technology of Guangdong Province (No. c1211220800571), the Natural Science Foundation of Guangdong Province and the Fundamental Research Funds for the Central Universities.

文章分享

1. 钌配合物稳定端粒DNA的作用及其诱导细胞凋亡分子机制的研究.PDF(464KB)

摘要/Abstract

端粒酶在肿瘤细胞中高表达，已经成为抗肿瘤药物的重要靶点，由于很多肿瘤细胞中富含G4-DNA，通过稳定G-四链体DNA的形成来抑制端粒酶的活性已成为抗癌药物的一个新策略. 本文设计了两种钌配合物，调查了这两种钌配合物稳定G4-DNA的能力，发现配合物2稳定端粒 G4-DNA的能力强于配合物1，配合物2能够诱导端粒 G4-DNA发生构型的转化，而配合物1不能诱导G4-DNA发生构型的转化，这项研究结果证明，钌配合物与G4-DNA的作用能力与配体的平面性有关. 在抗肿瘤活性方面，配合物2表现出更强的抗肿瘤活性，尤其是对HepG2细胞具有较强的抑制作用，推测其是以端粒酶为靶点发挥的抗肿瘤作用. 配合物2能够诱导肿瘤细胞凋亡，能诱导G1期细胞阻滞和DNA碎片的形成（细胞凋亡的特征）. 据此推测本论文设计的钌配合物是一个潜在的抗肿瘤药物.

关键词: 端粒酶, G4-DNA, 钌配合物, 抗肿瘤活性

Telomerase is highly expressed in tumor cells, which has become an important target of anticancer drugs. Since many tumor cells were rich in G4-DNA, we investigated the capabilities of these two ruthenium complexes to stabilize G4-DNA. Two ruthenium(Ⅱ) complexes were synthesized and characterized via electrospray ionization-mass spectrometry. Since many tumor cells were rich in G4-DNA, we investigated the capabilities of these two ruthenium complexes to stabilize G4-DNA. The interactions of these compounds with G-quadruplex DNA have been studied by fluorescence spectroscopy and circular dichroism (CD) spectroscopy. The stabilization of quadruplex DNA to complex 2 was better than complex 1, and complex 2 can induce telomeric G-quadruplex to occur conformation transformation, while complex 1 cannot. The results showed that the interaction of ruthenium complexes with G-quadruplex DNA was related with the plane of ligand. A novel visual method has been developed for making a distinction between ct-DNA and HTG21 by our Ru complexes binding hemin to form the hemin-G-quadruplex DNAzyme. The results showed that in the presence of complex 1 or 2, HTG21 can fold into a G-quadruplex, but CT-DNA cannot form the G-quadruplex structure. The anticancer activities of these complexes were evaluated by using the MTT assay. Interestingly, the anti-tumor activity of complex 2 exhibited greater inhibition to HepG2 cells, suggesting the ruthenium complexes were much less toxic towards normal cells, and speculated that it targeted the telomeric G-quadruplex was play a role on anti-tumor effect. To further evaluate the characteristics of the death induced by complexes 1 and 2-treated cells staining with Hoechst is analyzed by fluorescence microscopy. These results indicated that complex 2 revealed antiproliferative activities by apoptosis. We also used PI staining and flow cytometry to assess whether the ruthenium complex 2 affected cell cycle progression in HepG2 cells. Complex 2 is a potential antitumor drugs that can induce cancer cell death by acting on cell cycle arrest in G1 phase and the formation of DNA fragments (apoptosis characteristics).

Key words: telomerase, G-quadruplex DNA, ruthenium(Ⅱ) complexes, anti-tumor activity

引用此文

刘莹, 陈小曼, 张朗棋, 孙冬冬, 周艳晖, 陈兰美, 刘杰. 钌配合物稳定端粒DNA的作用及其诱导细胞凋亡分子机制的研究[J]. 化学学报, 2014, 72(4): 473-480.

Liu Ying, Chen Xiaoman, Zhang Langqi, Sun Dongdong, Zhou Yanhui, Chen Lanmei, Liu Jie. Stabilization of Telomere DNA, and Mechanism of Apoptosis of Tumor Cells Induced by Ruthenium Complexes[J]. Acta Chimica Sinica, 2014, 72(4): 473-480.

导出引用 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

分享此文

参考文献

[1] McEachern, M. J.; Krauskopf, A.; Blackburn, E. H. Annu. Rev. Genet. 2000, 34, 331.

[2] Shay, J. W.; Wright, W. E. Carcinogenesis 2005, 26, 867.

[3] Shay, J. W.; Wright, W. E. Nat. Rev. Drug. Discov. 2006, 5, 577.

[4] Seenisamy, J.; Bashyam, S.; Gokhale, V.; Vankayalapati, H.; Sun, D.; Siddiqui-Jain, A.; Streiner, N.; Shin-Ya, K.; White, E.; Wilson, W. D. J. Am. Chem. Soc. 2005, 127, 2944.

[5] Yu, H.; Wang, X.; Fu, M.; Ren, J.; Qu, X. Nucleic Acids Res. 2008, 36, 5695.

[6] Zhao, C.; Geng, J.; Feng, L.; Ren, J.; Qu, X. Chem. Eur. J. 2011, 17, 8209.

[7] Rickling, S.; Ghisdavu, L.; Pierard, F.; Gerbaux, P.; Surin, M.; Murat, P.; Defrancq, E.; Moucheron, C.; Mesmaeker, K. D. Chem. Eur. J. 2010, 16, 3951.

[8] Shi, S.; Geng, X.; Zhao, J.; Yao, T.; Wang, C.; Yang, D.; Zheng, L.; Ji, L. Biochimie. 2010, 92, 370.

[9] Shi, S.; Zhao, J.; Geng, X.; Yao, T.; Huang, H.; Liu, T.; Zheng, L.; Li, Z.; Yang, D.; Ji, L. Dalton. Trans. 2010, 39, 2490.

[10] Sun, D.; Zhang, R.; Yuan, F.; Liu, D.; Zhou, Y.; Liu, J. Dalton. Trans. 2012, 41, 1734.

[11] Yu, Q.; Liu, Y.; Wang, C.; Sun, D.; Yang, X.; Liu, Y.; Liu, J. PloS one 2012, 7, e50902.

[12] Rezler, E. M.; Seenisamy, J.; Bashyam, S.; Kim, M.-Y.; White, E.; Wilson, W. D.; Hurley, L. H. J. Am. Chem. Soc. 2005, 127, 9439.

[13] Gonçalves, D. P.; Rodriguez, R.; Balasubramanian, S.; Sanders, J. K. Chem. Commun. 2006, 4685.

[14] Tan, L.; Shen, J.; Liu, J.; Zeng, L.; Jin, L.; Weng, C. Dalt Trans. 2012, 41, 4575.

[15] Xie, Y.-Y.; Huang, H.-L.; Yao, J.-H.; Lin, G.-J.; Jiang, G.-B.; Liu, Y.-J. Chem. Eur. J. 2013, 63, 603.

[16] Tan, C.; Lai, S.; Wu, S.; Hu, S.; Zhou, L.; Chen, Y.; Wang, M.; Zhu, Y.; Lian, W.; Peng, W. J. Med. Chem. 2010, 53, 7613.

[17] Sun, D.; Liu, Y.; Liu, D.; Zhang, R.; Yang, X.; Liu, J. Chem. Eur. J. 2012, 18, 4285.

[18] (a) Jiang, S.; Wang, K.; Liu, F.; Zhang, Y.; Gao, L. Acta Chim. Sinica 2005, 63, 783. (蒋尚达, 王科志, 刘芙蓉, 张永安, 高丽华, 化学学报, 2005, 63, 783); (b) Zhao, L.; Wu, B.; Gao, L.; Wang, K. Acta Chim. Sinica 2006, 64, 1402. (赵琳, 吴宝燕, 高丽华, 王科志, 化学学报, 2006, 64, 1402).

钌配合物稳定端粒DNA的作用及其诱导细胞凋亡分子机制的研究

Stabilization of Telomere DNA, and Mechanism of Apoptosis of Tumor Cells Induced by Ruthenium Complexes

PDF

补充材料

可视化

被引次数

摘要/Abstract

引用此文

分享此文

参考文献

相关文章 15

编辑推荐

相关统计

本文评价

[1]	李志凯, 罗思琪, 陈敏, 於秀君, 李霄鹏. 双三联吡啶钌配合物的研究进展^★[J]. 化学学报, 2023, 81(10): 1447-1461.
[2]	刘启雁, 蔡戴宏, 戚永育, 乐学义. 司帕沙星及均三嗪衍生物铜(II)配合物与DNA作用及其抗肿瘤活性[J]. 化学学报, 2020, 78(3): 263-270.
[3]	张佳玉, 周晓毓, 周曼, 贾红霞. 基于杂交链式反应信号放大和磁分离技术荧光检测端粒酶活性[J]. 化学学报, 2016, 74(6): 513-517.
[4]	罗懿, 陈填烽, 黄晓纯, 王弋, 黄荫成, 郑文杰. 具有抗癌活性的新型硒杂环化合物的合成及其与牛血清蛋白的相互作用[J]. 化学学报, 2012, 70(11): 1295-1303.
[5]	刘海彬, 徐惠娟, 吕萍, 潘宁宁, 李双奇. 6,7-二甲氧基-4-哌嗪喹唑啉缩氨基硫脲衍生物的合成及体外抗肿瘤活性研究[J]. 化学学报, 2012, 0(05): 674-678 .
[6]	周双生, 薛璇, 姜波, 鲁传华, 田玉鹏, 蒋明华. 姜黄素类铂(II)配合物的合成及其抗肿瘤活性[J]. 化学学报, 2011, 69(19): 2335-2340.
[7]	尹传奇, 刘珺, 柏正武. 一种水溶性氢氧根钌配合物的合成及其对乙腈的催化水化作用[J]. 化学学报, 2011, 69(17): 2021-2025.
[8]	卜站伟, 王志强, 秦刚, 崔元臣, 曹少魁. 2,2 -联吡啶钌配合物催化CO₂制备环状碳酸酯机理研究[J]. 化学学报, 2010, 68(18): 1871-1875.
[9]	董环文李科郑灿辉刘嘉吕志良. 3-胺基取代苯并吡喃酮类化合物的设计合成及抗肿瘤活性[J]. 化学学报, 2009, 67(8): 819-824.
[10]	尹传奇,冯权武,柏正武. 单氢钌配合物催化氢化苯乙烯的位阻效应[J]. 化学学报, 2009, 67(6): 519-522.
[11]	胡国强, 张忠泉, 王海燕, 毋小魁, ??新, 杜钢军, 谢松强, 黄文龙, 张惠斌. 氟喹诺酮C3稠杂环体系的合成及抗肿瘤活性(III): 恩诺沙星均三唑并噻二嗪酮衍生物[J]. 化学学报, 2009, 67(22): 2592-2596.
[12]	王海滔胡婷婷张黔玲刘剑洪任祥忠李翠华王芳张培新. 钌(II)多吡啶配合物的合成、荧光性质及与脱氧核糖核酸DNA的作用机制研究[J]. 化学学报, 2008, 66(13): 1565-1571.
[13]	厉嘉云, 彭家建, 邱化玉, 蒋剑雄, 邬继荣, 倪勇, 来国桥. 过渡金属钌、铑配合物在室温离子液体中催化硅氢加成反应的研究[J]. 化学学报, 2007, 65(8): 715-721.
[14]	尹传奇, 冯权武, 陈瑶, 柏正武, 李早英. 钌配合物催化氢化CO₂生成甲酸反应中的醇促进效应[J]. 化学学报, 2007, 65(8): 722-726.
[15]	尹传奇,陈瑶,冯权武,柏正武,王长芳,李早英. 单氢钌配合物与水和2,2,2-三氟乙醇的作用机理[J]. 化学学报, 2007, 65(20): 2320-2324.